Home / Science / Brain Cell 'Glue' Holds Autism Treatment Key
Brain Cell 'Glue' Holds Autism Treatment Key
27 Aug
Summary
- Scientists mapped how genetic mutations alter brain cell protein interactions.
- Mutations change how proteins stick together, affecting neuron development.
- New findings offer pathways for developing targeted autism drug treatments.
Researchers have charted how genetic mutations impact protein interactions within cells, providing critical insights into the development of severe autism. This breakthrough maps previously unknown biological territories, advancing the understanding of the condition's molecular underpinnings. By studying how proteins function and interact, scientists aim to develop targeted therapies.
The study identified over 1,000 proteins interacting with 100 autism-linked proteins. Mutations were found to alter the binding strength between these proteins, affecting how neurons develop in the brain. For instance, a FOXP1 mutation disrupted the normal pairing of FOXP1 and FOXP4 proteins, leading to uncontrolled cell division.
This detailed understanding of autism mutations opens avenues for novel drug treatments. Strategies could involve restoring protein 'glue' or blocking rogue proteins from disrupting gene activity. The discovery that many autism-related proteins share common pathways offers hope for developing unified treatments applicable to various genetic causes of severe autism.
